2024. CRISPR-Cas9 Mediated Epigenetic Reprogramming of Cardiac Fibroblasts as a Therapeutic Strategy for Post-Infarction Myocardial Remodeling. International Journal of Medical Science Research and Development (ISCSITR-IJMSRD). 5, 2 (Feb. 2024), 1–9.